Ann-Muriel Steff | Program Lead
CEPI

Ann-Muriel Steff is a dynamic and innovative scientific leader in the field of vaccines and infectious diseases. With a strong background in vaccines R&D across CROs, Pharma and non-profit organizations. Ann-Muriel spent over a decade at GSK Vaccines, in diverse roles, in particular Head of Preclinical R&D and Discovery Project Leader. She is currently serving as the Program Leader for Disease X at the Coalition for Epidemic Preparedness Innovations (CEPI) where she leads efforts to develop vaccines to combat emerging infectious diseases that pose a threat to global health.

With a deep commitment to advancing vaccine R&D, Ann-Muriel has a proven track record of successfully leading multidisciplinary teams in diverse life sciences organizations and collaborating with stakeholders to drive innovation and accelerate the development of life-saving vaccines.

As a speaker at the World Vaccine Congress Washington 2025, Ann-Muriel will share her insights and expertise on R&D and strategic partnering in the global vaccine ecosystem. Her presentation promises to offer valuable perspectives on the latest trends and developments in vaccine research and innovation, as well as strategies for enhancing collaboration and driving progress towards a world free from the threat of infectious diseases.